Elder Pharmaceuticals has announced that the wholly owned Dubai subsidiary of the company has made an unsolicited offer to NeutraHealth Plc, UK, at an indicative partial offer price of 5.5 pence per share..
The approach may or may not lead to a partial offer that would result in the subsidiary`s shareholding increasing from 21% to between 50 and 60%.
No comments:
Post a Comment